High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients

• Vanessa Regina Maciel Uzan,

  Affiliation Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil

  ⨯
• André van Helvoort Lengert,

  Affiliation Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Érica Boldrini,

  Affiliation Barretos Children’s Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Valter Penna,

  Affiliation Department of Orthopedic Surgery, Barretos Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Cristovam Scapulatempo-Neto,

  Affiliations Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil, Department of Pathology, Barretos Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Carlos Alberto Scrideli,

  Affiliation Department of Pediatrics, Medicine School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil

  ⨯
• Alberto Paiva de Moraes Filho,

  Affiliation Department of Radiology, Barretos Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Carlos Eduardo Bezerra Cavalcante,

  Affiliation Department of Radiology, Barretos Children’s Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Cleyton Zanardo de Oliveira,

  Affiliation Center for Research Support (NAP), Barretos Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Luiz Fernando Lopes ,

  * E-mail: daniel.vidal@hcancerbarretos.com.br (DOV); lf.lopes@yahoo.com (LFL)

  Affiliation Barretos Children’s Cancer Hospital, Barretos, SP, Brazil

  ⨯
• Daniel Onofre Vidal

  * E-mail: daniel.vidal@hcancerbarretos.com.br (DOV); lf.lopes@yahoo.com (LFL)

  Affiliation Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil

  ⨯